GlassScriptPhysician profile
Anandbir Bath
NPI 1063933851
$17,322.15
in general payments reported to CMS, 2019-2025
33 companies · $2,402 in 2025
The $2,402 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $95.07 · 2021: $556 · 2022: $2,434 · 2023: $7,253 · 2024: $4,583 · 2025: $2,402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $6,000 · Food and Beverage: $5,552 · Travel and Lodging: $2,522 · Education: $164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $6,000.00 |
| Food and Beverage | $5,552.10 |
| Travel and Lodging | $2,521.50 |
| Education | $164.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,502.93 | 2021-2025 | Optis, Assurity, Amplatzer Amulet |
| Medtronic, INC. | $3,163.88 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Spiderfx |
| Biotronik INC. | $2,433.68 | 2022 | |
| Boston Scientific Corporation | $1,555.60 | 2023-2025 | Versacross Connect Laac Access Solution, Ekosonic, Watchman Access System |
| Abiomed | $451.39 | 2024-2025 | Impella |
| Penumbra, INC. | $437.73 | 2025 | Indigo System |
| Shockwave Medical, INC | $353.20 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| E.R. Squibb & Sons, L.L.C. | $309.97 | 2023-2024 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $306.77 | 2024-2025 | |
| Inari Medical, INC. | $252.75 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cardiva Medical, INC. | $215.25 | 2023-2024 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Astrazeneca Pharmaceuticals LP | $207.66 | 2020-2025 | |
| Stryker Corporation | $173.05 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Flowtriever |
| Edwards Lifesciences Corporation | $158.89 | 2024 | Sapien 3 Ultra Resilia |
| Chiesi USA, INC. | $120.21 | 2023-2024 | Cleviprex, Kengreal |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $94.07 | 2024 | Assure Wcd |
| Merck Sharp & Dohme LLC | $79.05 | 2025 | Verquvo, Capvaxive |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $72.98 | 2024-2025 | Lifevest |
| Cordis US Corp. | $63.96 | 2024 | Radial 360 |
| Amgen INC. | $60.47 | 2023-2025 | Repatha, Repatha |
| Baxter Healthcare | $39.16 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Lantheus Medical Imaging, INC. | $36.03 | 2023-2025 | Definity |
| Lexicon Pharmaceuticals, INC. | $33.91 | 2023-2024 | Inpefa |
| Cvrx, INC. | $25.26 | 2025 | Barostim Neo System |
| Bard Peripheral Vascular, INC. | $22.78 | 2024 | Lutonix Drug Coated Balloon |
| Novo Nordisk INC | $21.88 | 2025 | Wegovy |
| Janssen Pharmaceuticals, INC | $21.41 | 2024 | Xarelto |
| W. L. Gore & Associates, INC. | $21.20 | 2024 | Gore Excluder Aaa Endoprosthesis |
| Kiniksa Pharmaceuticals International, Plc | $19.47 | 2024 | Arcalyst |
| Pfizer INC. | $18.18 | 2024 | |
| Zoll Circulation INC | $17.13 | 2024 | Therox Ds2 Console, Catheter, Downstream Cartridge |
| Philips North America LLC | $16.20 | 2023 | |
| Biosense Webster, INC. | $16.05 | 2024 | Na |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anandbir Bath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.